SEARCH

SEARCH BY CITATION

References

  • Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL and Manolagas SC (2000) Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res, 15, 663673.
  • Akhter MP, Cullen DM, Gong G and Recker RR (2001) Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice. Bone, 29, 121125.
  • Babcook JS, Leslie KB, Olsen OA, Salmon RA and Schrader JW (1996) A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proc Natl Acad Sci USA, 93, 78437848.
  • Balemans W et al. (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet, 10, 537543.
  • Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH and Van Hul W (2002) Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms. Bone, 31, 515519.
  • Beighton P (1988) Sclerosteosis. J Med Genet, 25, 200203.
  • Beighton P, Durr L and Hamersma H (1976) The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. Ann Intern Med, 84, 393397.
  • Brunkow ME et al. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet, 68, 577589.
  • Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE and Lowik CW (2002) Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology, 143, 15451553.
  • Desbois C, Hogue DA and Karsenty G (1994) The mouse osteocalcin gene cluster contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem, 269, 11831190.
  • Fujii M et al. (1999) Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell, 10, 38013813.
  • Gaddy-Kurten D, Coker JK, Abe E, Jilka RL and Manolagas SC (2002) Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. Endocrinology, 143, 7483.
  • Gazzerro E, Gangji V and Canalis E (1998) Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J Clin Invest, 102, 21062114.
  • Gong Y et al. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513523.
  • Groppe J et al. (2002) Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature, 420, 636642.
  • Hanaoka E, Ozaki T, Nakamura Y, Moriya H, Nakagawara A and Sakiyama S (2000) Overexpression of DAN causes a growth suppression in p53-deficient SAOS-2 cells. Biochem Biophys Res Commun, 278, 2026.
  • Hansen H (1967) Sklerosteose. In Opitz,H. and Schmid,F. (eds), Handbuch der Kinderheilkunde Springer-Verlag, Berlin, Vol. 6, pp. 351355.
  • Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS and Hinck AP (2002) Crystal structure of the human TβR2 ectodomain–TGF-β3 complex. Nature Struct Biol, 9, 203208.
  • Hill SC, Stein SA, Dwyer A, Altman J, Dorwart R and Doppman J (1986) Cranial CT findings in sclerosteosis. Am J Neuroradiol, 7, 505511.
  • Kirsch T, Sebald W and Dreyer MK (2000) Crystal structure of the BMP-2–BRIA ectodomain complex. Nature Struct Biol, 7, 492496.
  • Kusu N, Laurikkala J, Imanishi M, Usui H, Konishi M, Miyake A, Thesleff I and Itoh N (2003) Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem, 278, 2411324117.
  • Little RD et al. (2002) A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet, 70, 1119.
  • Lyons GE, Schiaffino S, Sassoon D, Barton P and Buckingham M (1990) Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol, 111, 242736.
  • Merino R, Rodriguez-Leon J, Macias D, Ganan Y, Economides AN and Hurle JM (1999) The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development, 126, 55155522.
  • Nomura S and Takano-Yamamoto T (2000) Molecular events caused by mechanical stress in bone. Matrix Biol, 19, 9196.
  • Oreffo RO, Kusec V, Romberg S and Triffitt JT (1999) Human bone marrow osteoprogenitors express estrogen receptor-α and bone morphogenetic proteins 2 and 4 mRNA during osteoblastic differentiation. J Cell Biochem, 75, 382392.
  • Pereira RC, Economides AN and Canalis E (2000) Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts. Endocrinology, 141, 45584463.
  • Pittenger MF et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143147.
  • Stein S et al. (1983) Sclerosteosis: neurogenetic and pathophysiologic analysis of an American kinship. Neurology, 33, 267277.
  • Suzawa M, Takeuchi Y, Fukumoto S, Kato S, Ueno N, Miyazono K, Matsumoto T and Fujita T (1999) Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology, 140, 21252133.
  • Truswell AS (1958) Osteopetrosis with syndactyly, a morphologic variant of Albers–Schonberg disease. J Bone Joint Surg (Br), 40, 208218.
  • Tsumaki N, Nakase T, Miyaji T, Kakiuchi M, Kimura T, Ochi T and Yoshikawa H (2002) Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res, 17, 898906.
  • Turner CH, Robling AG, Duncan RL and Burr DB (2002) Do bone cells behave like a neuronal network? Calcif Tissue Int, 70, 435442.
  • van der Horst G, van Bezooijen R, Deckers M, Hoogendam J, Visser A, Lowik C and Karperien M (2002) Differentiation of murine pre-osteoblastic KS483 cells depends on autocrine BMP signalling during all phases of osteoblast formation. Bone, 31, 661669.
  • Wang EA, Israel DI, Kelly S and Luxenberg DP (1993) Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors, 9, 5771.
  • Zhang D, Ferguson CM, O'Keefe RJ, Puzas JE, Rosier RN and Reynolds PR (2002) A role for the BMP antagonist chordin in endochondral ossification. J Bone Miner Res, 17, 293300.
  • Zimmerman LB, De Jesus-Escobar JM and Harland RM (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell, 86, 599606.